Charlotte Newbury
Charlotte Newbury is the Americas Head of Enterprise Risk at Deutsche Bank. In this role she is responsible for maintaining a comprehensive view of DB’s risk profile including emerging risks and trends. She led the development of the Risk Identification framework in the region and is chair of the regional ESG risk forum.
Charlotte established her career in finance as a market risk manager, building over 13 years’ experience managing risk across multiple product lines. She has a master’s degree in mathematics from the University of Manchester. Charlotte is based in NYC as well as the Adirondacks where she brings her passion for climate risk to bear on grassroots initiatives.
Dr. Erwin Gianchandani
Dr. Erwin Gianchandani is the U.S. National Science Foundation’s assistant director for Technology, Innovation and Partnerships, leading the newly established TIP Directorate.
Gianchandani has worked at NSF since 2012. Prior to becoming the assistant director for TIP, he served as the senior advisor for Translation, Innovation and Partnerships for over a year, where he helped develop plans for the new TIP Directorate in collaboration with colleagues at NSF, other government agencies, industry and academia.
During the previous six years, Gianchandani was the NSF deputy assistant director for Computer and Information Science and Engineering, twice serving as acting assistant director for CISE. Gianchandani’s leadership and management of CISE included the formulation and implementation of the directorate's $1 billion annual budget, strategic and human capital planning, and oversight of day-to-day operations for a team of over 130.
Gianchandani has led the development and launch of several new NSF initiatives, including the Smart & Connected Communities program, Civic Innovation Challenge, Platforms for Advanced Wireless Research, and the National Artificial Intelligence Research Institutes.
Before joining NSF in 2012, Gianchandani was the inaugural director of the Computing Community Consortium, providing leadership to the computing research community in identifying and pursuing bold, high-impact research directions such as health information technology and sustainable computing.
Gianchandani has published extensively and presented at international conferences on computational systems biology. He holds a bachelor's degree in computer science and master's and doctoral degrees in biomedical engineering, all from the University of Virginia.
In 2021, Gianchandani received the Distinguished Presidential Rank Award, awarded to members of the Federal Government’s Senior Executive Service for sustained extraordinary accomplishment. In 2018, he was awarded the Outstanding Young Engineering Graduate Award from the University of Virginia.
Nikolai Sopko
Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr. Sopko is currently the Chief Scientific Officer and Vice President of Research and Development of PolarityTE where he applies his passion for patient care and basic science
Camillo Ricordi
Camillo Ricordi, M.D. is the Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, Professor of Biomedical Engineering, and Microbiology and Immunology at the University of Miami (UM), Florida, where he serves as Director of the Diabetes Research Institute (DRI) and the Cell Transplant Program. Dr. Ricordi been serving as Responsible Head of the NIH-funded cGMP (current Good Manufacturing Practices) Human Cell Processing Facility (1993-present), for the manufacturing of advanced human cell and other biologic products, for research and clinical applications at the University of Miami, in the U.S. and worldwide. Dr. Ricordi has also served as Senior Associate Dean for Research (2003-2006) and chaired the Dean’s Research Cabinet (2006-2012) at the UM Miller School of Medicine.
Thomas Serena
Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.
To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.
He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.
Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.
Davide Vigano
Sensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line. He acted as Vice President of the Worldwide SMSP Medium Business division which he grew 18% YOY to over $14B. Davide also managed the Italian Marketing, Business and Enterprise operations for five years and brought it to number one in the world for contribution margin, 6th largest Microsoft subsidiary in the world by revenues.